Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $559.6700 (-1.55%) ($546.9300 - $565.9900) on Tue. Nov. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 46 | Latest Price | $559.6700(-1.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(43%) SPLV(37%) IVW(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -1.135% in a week (0% probabilities). VIXM(-21%) TBT(-8%) VXX(-7%) UUP(-6%) EDOC(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $574.36 | 5 Day Moving Average | $576.4(-2.9%) | 10 Day Moving Average | $565.78(-1.08%) | 20 Day Moving Average | $574.36(-2.56%) | To recent high | -11.1% | To recent low | 2.9% | Market Cap | $59.341b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |